Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 11Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Endometrial Neoplasms 3Colorectal Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Site 1Melanoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Digestive System Neoplasms 1Carcinoma, Renal Cell 1Bites and Stings 1Adenocarcinoma 1

Interventions

Nivolumab 3osimertinib 2Pemetrexed 2Cetuximab 2Carboplatin 2spartalizumab 1napabucasin 1guadecitabine 1gallium 68 PSMA-11 1ficlatuzumab 1exemestane 1entinostat 1dostarlimab 1darolutamide 1apalutamide 1abexinostat 1Tyrosine Kinase Inhibitors 1Ramucirumab 1Radiosurgery 1Paclitaxel 1Leucovorin 1Irinotecan 1Interleukin-2 1Indocyanine Green 1HuMax-IL8 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms by Site × dostarlimab × Clear all
NCT05980416 2025-11-14

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Elevation Oncology

Phase 1 Terminated
88 enrolled 18 charts
Gastrointestinal

Adenocarcinoma, Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡